Skip to main content

Table 1 Patients demographics

From: Clinical significance and risk factors of urethrovesical anastomotic urinary leakage following robot-assisted radical prostatectomy: a multi-institutional study

 

Leakage (+)

Leakage (−)

Total

Minor

Major

Minor + major

Anastomotic urinary leakage after RARP

Number of patients (%)

34 (3.7)

22 (2.4)

56 (6.1)

860 (93.9)

916

Age, (years)

68.5 (64–72)

65 (58–70)

68 (63–72)

68 (64–73)

68 (64–73)

BMI (kg/m2)

24.1 (22.2–26.5)

25.6 (24.4–28.1)

24.9 (22.9–26.7)

23.8 (21.9–25.6)

23.9 (22–25.6)

PSA (ng/mL)

8.8 (6.2–12.6)

8.3 (5.9–15.3)

8.5 (6.2–12.9)

7.6 (5.5–11.0)

7.6 (5.6–11.1)

Operation duration (min)

279 (203–341)

295 (232–379)

289 (215–349)

240 (195–283)

241 (196–287)

Console duration (min)

212.5 (155–266)

233 (168–322)

221.5 (164–271)

183 (143–221)

184 (145–226)

Prostate weight (g)

43.1 (34–70)

50.5 (40–74)

46.5 (38–72)

40.5 (32–52)

41 (32–53)

Blood loss volume (mL)

300 (100–725)

352 (174–666)

326 (150–700)

221 (100–442)

230 (100–450)

pGS ≥ 8 (%)

29.4

22.7

26.8

28.2

29.8

pT stage ≥ 3 (%)

23.5

40.9

30.4

30.6

30.6

PSM (%)

17.6

18.2

17.9

21.3

21.7

  1. Median values are shown (interquartile range)
  2. RARP, robot-assisted radical prostatectomy; BMI, body mass index; PSA, prostate specific antigen; pGS, pathological Gleason score; PSM, positive surgical margin